Prof Datin Paduka Dr Teo Soo-Hwang

Dr Teo led the research portfolio at Cancer Research Malaysia, where she and her team spearheaded the largest study of genomic profiles on Asian breast cancers, providing valuable insights into treatment and survival for Asian women. From humble beginnings with limited resources, the organisation has made discoveries that enhance access to life-saving treatments and developed solutions for low-income patients.

Their efforts contributed to the development of the first investigator-led clinical trial testing new therapies for Asian breast cancer patients. In a pioneering move, Teo initiated the Malaysian Breast Cancer Genetic Study, leading to the identification of genes associated with cancer risk and the creation of the Asian Genetic Risk Calculator. Her hope for this creation is to transform the access of genetics to the Asian population and empower individuals to make the right decisions about prevention of the disease.

Her research findings have garnered numerous research grants, including the prestigious Wellcome Trust Collaborative Science Award and the Newton Grant Awards. Among her proudest moments is being the first Malaysian to be conferred an Honorary Officer of the British Empire by Queen Elizabeth II, a historic recognition for her contributions to medical research. She is also the recipient of the Well-Being Award at this year’s Front & Female Awards Malaysia 2024 for her work in addressing the well-being of women and girls, whether physical, mental, social, or sexual.